Drug Profile
Verapamil - Eisai
Alternative Names: E-0103; VasolanLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Abbott Laboratories
- Developer Eisai Co Ltd
- Class Antihypertensives; Antimigraines; Class IV antiarrhythmics; Ischaemic heart disorder therapies; Nitriles; Phenethylamines; Small molecules; Vasodilators
- Mechanism of Action Calcium channel antagonists; P-glycoprotein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Atrial fibrillation; Ischaemic heart disorders; Paroxysmal supraventricular tachycardia; Supraventricular tachycardia
Most Recent Events
- 21 Mar 2013 Chemical structure added (USAN); str saved as MOL and PNG files
- 21 May 2011 Registered for Supraventricular tachycardia in Japan (PO)
- 20 May 2011 Registered for Supraventricular tachycardia in Japan (IV)